Patents by Inventor Juha HIMANEN

Juha HIMANEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for cancer treating conditions relating to over expressions of EphA2
    Patent number: 10501553
    Abstract: An anti-EphA2 scFv single-chain antibody binds with high specificity for EphA2 and blocks ephrin binding to Eph-A2. The antibody may be linked with other antigen-targeting domains, such as an anti-CD20 domain, or conjugated with toxins, or used in combination therapy to for treatment of conditions related to overexpression of EphA2. The antibody may also be expressed in vivo by an expression vector that is designed to facilitate such treatment.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: December 10, 2019
    Inventors: Dimitar B Nikolov, Juha Himanen, Urpo Lamminmaki, Hanna Sanmark
  • METHODS AND COMPOSITIONS FOR CANCER TREATING CONDITIONS RELATING TO OVER EXPRESSIONS OF EPHA2
    Publication number: 20170349663
    Abstract: An anti-EphA2 scFv single-chain antibody binds with high specificity for EphA2 and blocks ephrin binding to Eph-A2. The antibody may be linked with other antigen-targeting domains, such as an anti-CD20 domain, or conjugated with toxins, or used in combination therapy to for treatment of conditions related to overexpression of EphA2. The antibody may also be expressed in vivo by an expression vector that is designed to facilitate such treatment.
    Type: Application
    Filed: November 18, 2015
    Publication date: December 7, 2017
    Inventors: Dimitar B. NIKOLOV, Juha HIMANEN